Return to homepagePandemic Pact

COVID-19 Supplement #4 for CoVPN 5002 Prevalence Study

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3UM1AI148685-02S2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $2,229,401

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    PROFESSOR/DIR SLU CENTER FOR VACCINE DEV Daniel Hoft

  • Research Location

    United States of America

  • Lead Research Institution

    SAINT LOUIS UNIVERSITY

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Impact/ effectiveness of control measures

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Saint Louis University (SLU) seeks to expand its service to the Vaccine and Treatment Evaluation Unit (VTEU) network providing resources and expertise to help the network achieve its objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics for COVID-19.